143 related articles for article (PubMed ID: 23530623)
1. Identification of selective inhibitors for human neuraminidase isoenzymes using C4,C7-modified 2-deoxy-2,3-didehydro-N-acetylneuraminic acid (DANA) analogues.
Zhang Y; Albohy A; Zou Y; Smutova V; Pshezhetsky AV; Cairo CW
J Med Chem; 2013 Apr; 56(7):2948-58. PubMed ID: 23530623
[TBL] [Abstract][Full Text] [Related]
2. Selective Inhibitors of Human Neuraminidase 3.
Guo T; Dätwyler P; Demina E; Richards MR; Ge P; Zou C; Zheng R; Fougerat A; Pshezhetsky AV; Ernst B; Cairo CW
J Med Chem; 2018 Mar; 61(5):1990-2008. PubMed ID: 29425031
[TBL] [Abstract][Full Text] [Related]
3. Identification of Selective Nanomolar Inhibitors of the Human Neuraminidase, NEU4.
Albohy A; Zhang Y; Smutova V; Pshezhetsky AV; Cairo CW
ACS Med Chem Lett; 2013 Jun; 4(6):532-7. PubMed ID: 24900705
[TBL] [Abstract][Full Text] [Related]
4. Homology modeling of human sialidase enzymes NEU1, NEU3 and NEU4 based on the crystal structure of NEU2: hints for the design of selective NEU3 inhibitors.
Magesh S; Suzuki T; Miyagi T; Ishida H; Kiso M
J Mol Graph Model; 2006 Oct; 25(2):196-207. PubMed ID: 16427342
[TBL] [Abstract][Full Text] [Related]
5. Molecular dynamics simulations of viral neuraminidase inhibitors with the human neuraminidase enzymes: Insights into isoenzyme selectivity.
Richards MR; Guo T; Hunter CD; Cairo CW
Bioorg Med Chem; 2018 Oct; 26(19):5349-5358. PubMed ID: 29903413
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, and biological evaluation of human sialidase inhibitors. Part 1: selective inhibitors of lysosomal sialidase (NEU1).
Magesh S; Moriya S; Suzuki T; Miyagi T; Ishida H; Kiso M
Bioorg Med Chem Lett; 2008 Jan; 18(2):532-7. PubMed ID: 18068975
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of human neuraminidase 3 (NEU3) by C9-triazole derivatives of 2,3-didehydro-N-acetyl-neuraminic acid.
Zou Y; Albohy A; Sandbhor M; Cairo CW
Bioorg Med Chem Lett; 2010 Dec; 20(24):7529-33. PubMed ID: 21036040
[TBL] [Abstract][Full Text] [Related]
8. Selective Inhibitors of Human Neuraminidase 1 (NEU1).
Guo T; Héon-Roberts R; Zou C; Zheng R; Pshezhetsky AV; Cairo CW
J Med Chem; 2018 Dec; 61(24):11261-11279. PubMed ID: 30457869
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of selective inhibitors against V. cholerae sialidase and human cytosolic sialidase NEU2.
Khedri Z; Li Y; Cao H; Qu J; Yu H; Muthana MM; Chen X
Org Biomol Chem; 2012 Aug; 10(30):6112-20. PubMed ID: 22641268
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic Effect of Neuraminidase-1-Selective Inhibition in Mouse Models of Bleomycin-Induced Pulmonary Inflammation and Fibrosis.
Luzina IG; Lillehoj EP; Lockatell V; Hyun SW; Lugkey KN; Imamura A; Ishida H; Cairo CW; Atamas SP; Goldblum SE
J Pharmacol Exp Ther; 2021 Jan; 376(1):136-146. PubMed ID: 33139318
[TBL] [Abstract][Full Text] [Related]
11. The NEU1-selective sialidase inhibitor, C9-butyl-amide-DANA, blocks sialidase activity and NEU1-mediated bioactivities in human lung in vitro and murine lung in vivo.
Hyun SW; Liu A; Liu Z; Cross AS; Verceles AC; Magesh S; Kommagalla Y; Kona C; Ando H; Luzina IG; Atamas SP; Piepenbrink KH; Sundberg EJ; Guang W; Ishida H; Lillehoj EP; Goldblum SE
Glycobiology; 2016 Aug; 26(8):834-49. PubMed ID: 27226251
[TBL] [Abstract][Full Text] [Related]
12. 2-Deoxy-2,3-didehydro-N-acetylneuraminic acid analogues structurally modified at the C-4 position: synthesis and biological evaluation as inhibitors of human parainfluenza virus type 1.
Ikeda K; Sato K; Kitani S; Suzuki T; Maki N; Suzuki Y; Sato M
Bioorg Med Chem; 2006 Dec; 14(23):7893-7. PubMed ID: 16908163
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and evaluation of 4-O-alkylated 2-deoxy-2,3-didehydro-N-acetylneuraminic acid derivatives as inhibitors of human parainfluenza virus type-3 sialidase activity.
Tindal DJ; Dyason JC; Thomson RJ; Suzuki T; Ueyama H; Kuwahara Y; Maki N; Suzuki Y; von Itzstein M
Bioorg Med Chem Lett; 2007 Mar; 17(6):1655-8. PubMed ID: 17236768
[TBL] [Abstract][Full Text] [Related]
14. Molecular modeling of T. rangeli, T. brucei gambiense, and T. evansi sialidases in complex with the DANA inhibitor.
Lima AH; Souza PR; Alencar N; Lameira J; Govender T; Kruger HG; Maguire GE; Alves CN
Chem Biol Drug Des; 2012 Jul; 80(1):114-20. PubMed ID: 22416952
[TBL] [Abstract][Full Text] [Related]
15. 2-Deoxy-2,3-didehydro-N-acetylneuraminic acid analogs structurally modified by thiocarbamoylalkyl groups at the C-4 position: Synthesis and biological evaluation as inhibitors of human parainfluenza virus type 1.
Ikeda K; Sato K; Nishino R; Aoyama S; Suzuki T; Sato M
Bioorg Med Chem; 2008 Jul; 16(14):6783-8. PubMed ID: 18555688
[TBL] [Abstract][Full Text] [Related]
16. Human Neuraminidases: Structures and Stereoselective Inhibitors.
Bourguet E; Figurska S; Fra Czek MM
J Med Chem; 2022 Feb; 65(4):3002-3025. PubMed ID: 35170942
[TBL] [Abstract][Full Text] [Related]
17. Human Neuraminidase Isoenzymes Show Variable Activities for 9- O-Acetyl-sialoside Substrates.
Hunter CD; Khanna N; Richards MR; Rezaei Darestani R; Zou C; Klassen JS; Cairo CW
ACS Chem Biol; 2018 Apr; 13(4):922-932. PubMed ID: 29341588
[TBL] [Abstract][Full Text] [Related]
18. Isoenzyme-Selective Inhibitors of Human Neuraminidases Reveal Distinct Effects on Cell Migration.
Howlader MA; Guo T; Chakraberty R; Cairo CW
ACS Chem Biol; 2020 Jun; 15(6):1328-1339. PubMed ID: 32310634
[TBL] [Abstract][Full Text] [Related]
19. Inhibitor selectivity of a new class of oseltamivir analogs against viral neuraminidase over human neuraminidase enzymes.
Albohy A; Mohan S; Zheng RB; Pinto BM; Cairo CW
Bioorg Med Chem; 2011 May; 19(9):2817-22. PubMed ID: 21489803
[TBL] [Abstract][Full Text] [Related]
20. Syntheses of 2-deoxy-2,3-didehydro-N-acetylneuraminic acid analogues modified by N-sulfonylamidino groups at the C-4 position and biological evaluation as inhibitors of human parainfluenza virus type 1.
Nishino R; Ikeda K; Hayakawa T; Takahashi T; Suzuki T; Sato M
Bioorg Med Chem; 2011 Apr; 19(7):2418-27. PubMed ID: 21382718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
